RCT of Post-Suicide Attempt Case Management (ACTION-J) (ACTION-J)

A Randomized Controlled Multicenter Trial of Post-Suicide Attempt Case Management for the Prevention of Further Attempts in Japan (ACTION-J)

This study will determine the effectiveness of continuous follow-up care by case manager in preventing further suicide attempts

Study Overview

Status

Completed

Conditions

Detailed Description

It is well known that many subjects who survived a suicide attempt will make further suicide attempts, even after the medical treatment at critical emergency unit. To examine the effectiveness of continuous follow-up care by case manager after the suicide attempt, a randomized, controlled, multicenter trial by J-MISP (Japanese Multimodal Intervention Trials).This research project is one of the strategic research projects funded by The Japanese Ministry of Health, Labor and Welfare. In this study, J-MISP will implement the intervention for suicide attempters, a considerably high-risk group of further suicide attempts, who are transported by emergency services.

Study Type

Interventional

Enrollment (Actual)

914

Phase

  • Phase 3

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Fukuoka, Japan, 814-0128
        • Fukuoka University Hospital
      • Osaka, Japan
        • National Hospital Organization, Osaka Medical Center
      • Tokyo, Japan, 113-0022
        • Nihon Medical University Hospital
      • Tokyo, Japan, 142-0064
        • Showa University Hospital
    • Aichi
      • Toyoake, Aichi, Japan, 470-1192
        • Fujita Health University Hospital
    • Ibaraki
      • Mito, Ibaraki, Japan, 311-3198
        • National Hospital Organization, Mito Medical Center
      • Tsuchiura, Ibaraki, Japan, 300-0053
        • Tsuchiura Kyodo Hospital
      • Tsukuba, Ibaraki, Japan, 305-8558
        • Tsukuba Medical Center
    • Iwate
      • Morioka, Iwate, Japan, 020-0023
        • Iwate Medical University Hospital
    • Kanagawa
      • Sagamihara, Kanagawa, Japan, 228-0829
        • Kitazato University Hospital
      • Yokohama, Kanagawa, Japan, 232-0024
        • Yokohama City University Medical Center
    • Nara
      • Kashihara, Nara, Japan, 634-0813
        • Nara Medical University Hospital
    • Oita
      • Beppu, Oita, Japan, 874-8585
        • Oita Kouseiren Tsurumi Hospital
      • Yufu, Oita, Japan, 897-5503
        • Oita University Hospital
    • Osaka
      • Moriguchi, Osaka, Japan, 570-0074
        • Kansai Medical University Takii Hospital
      • Sayama, Osaka, Japan, 589-0014
        • Kinki University Hospital
    • Saitama
      • Kawagoe, Saitama, Japan, 350-8550
        • Saitama Medical University Medical Center
      • Moroyama, Saitama, Japan, 350-0495
        • Saitama Medical University Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

20 years and older (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  1. Over 20 years old
  2. Suffering from Axis I disorder
  3. Had intent for suicide (confirmed more than 2 times)
  4. Able to understand this study and provide informed consent
  5. Able to have interview before trial registry and psycho education at hospital
  6. Able to have interview for assessment at continuous follow-up care by case manager at the hospital

Exclusion Criteria:

  1. Not suffering from Axis I disorder as a primary diagnosis

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: PREVENTION
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: SINGLE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
EXPERIMENTAL: Case management
Case management, Usual clinical practice and Providing paper based information for suicide prevention
ACTIVE_COMPARATOR: Enhanced usual care
Usual clinical practice and Providing paper based information for suicide prevention

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
First recurrent suicide behavior (suicide attempted and completed suicide)
Time Frame: Minimum 1.5 year
Minimum 1.5 year

Secondary Outcome Measures

Outcome Measure
Time Frame
Any cause of death
Time Frame: Minimum 1.5 year
Minimum 1.5 year
Repeated recurrent incidence of suicide attempts
Time Frame: Minimum 1.5 year
Minimum 1.5 year
Utilization or personal or social resources
Time Frame: Minimum 1.5 year
Minimum 1.5 year
Number of self-injury
Time Frame: Minimum 1.5 year
Minimum 1.5 year
Health care utilization
Time Frame: Minimum 1.5 year
Minimum 1.5 year
Physical function
Time Frame: Minimum 1.5 year
Minimum 1.5 year
Beck hopeless scale
Time Frame: Minimum 1.5 year
Minimum 1.5 year
SF-36
Time Frame: Minimum 1.5 year
Minimum 1.5 year
Adverse events
Time Frame: Minimum 1.5 year
Minimum 1.5 year

Other Outcome Measures

Outcome Measure
Time Frame
Incidence proportion of the first episode of recurrent suicidal behaviour (attempted suicide or completed suicide)
Time Frame: at 1 month after the randomization
at 1 month after the randomization
Incidence proportion of the first episode of recurrent suicidal behaviour (attempted suicide or completed suicide)
Time Frame: at 3 months after the randomization
at 3 months after the randomization
Incidence proportion of the first episode of recurrent suicidal behaviour (attempted suicide or completed suicide)
Time Frame: at 6 months after the randomization
at 6 months after the randomization
Incidence proportion of the first episode of recurrent suicidal behaviour (attempted suicide or completed suicide)
Time Frame: at 12 months after the randomization
at 12 months after the randomization
Incidence proportion of the first episode of recurrent suicidal behaviour (attempted suicide or completed suicide)
Time Frame: at 18 months after the randomization
at 18 months after the randomization

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Yoshio Hirayasu, MD,PhD, Yokohama City University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

June 1, 2006

Primary Completion (ACTUAL)

June 1, 2011

Study Completion (ACTUAL)

October 1, 2013

Study Registration Dates

First Submitted

August 15, 2008

First Submitted That Met QC Criteria

August 15, 2008

First Posted (ESTIMATE)

August 18, 2008

Study Record Updates

Last Update Posted (ESTIMATE)

January 16, 2014

Last Update Submitted That Met QC Criteria

January 14, 2014

Last Verified

January 1, 2014

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • J-MISP-01
  • C000000444 (REGISTRY: UMIN-CTR)

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Suicide Attempt

Clinical Trials on Case management

3
Subscribe